[
    {
        "question": "Fluoroqinolone with least oral bioavailability-",
        "exp": "Ans. is 'a' i. e., Norfloxacin Pharmacokinetic characteristics and doses of fluoroquinolones C1. PROFLNORFLPEFLOFLLEVOFLGEM1. PRULIMOXI1. Oral bioavailability (%)60-8035-4590-10085-95-1007090852. Plasma protein binding (%)20-351520-30252555-7345403. Vo!, of distribution (L/kg)3-4221. 51. 3----24. Percent metabolized2025855-105->9070-805. Elimination t 1/2 (hr)3-54-68-145-88710-1210-156. Routes of administrationoral, i. v. oraloral, i. v. oral, i. v. oral, i. v. oraloraloral, i. v. 7. Dose (mg): oral250-750(BD)400(BD)400(BD)200-400(BD)500(OD)320(OD)600(OD)400(OD): i. v. 100-200--400200500 --400",
        "cop": 1,
        "opa": "Norfloxacin",
        "opb": "Ofloxacin",
        "opc": "Ciprofloxacin",
        "opd": "Levofloxacin",
        "subject_name": "Pharmacology",
        "topic_name": "Quinolones",
        "id": "9d384f9c-46cd-4191-b707-daa71ea772a9",
        "choice_type": "single"
    }
]